Page last updated: 2024-10-31

neostigmine and Congenital Stiff-Man Syndrome

neostigmine has been researched along with Congenital Stiff-Man Syndrome in 2 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Research Excerpts

ExcerptRelevanceReference
"This hypotonia has been linked to muscle relaxants and volatile anesthetics and may persist in spite of neostigmine administration and train-of-four (TOF) monitoring suggesting full reversal."2.82Postoperative hypotonia in a patient with stiff person syndrome: a case report and literature review. ( Backman, SB; Elsherbini, N; Weingartshofer, A, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Elsherbini, N1
Weingartshofer, A1
Backman, SB1
Saravanan, PK1
Paul, J1
Sayeed, ZA1

Reviews

1 review available for neostigmine and Congenital Stiff-Man Syndrome

ArticleYear
Postoperative hypotonia in a patient with stiff person syndrome: a case report and literature review.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2022, Volume: 69, Issue:11

    Topics: Anesthetics, Inhalation; Chelating Agents; Cholinesterase Inhibitors; Female; Humans; Muscle Hypoton

2022

Other Studies

1 other study available for neostigmine and Congenital Stiff-Man Syndrome

ArticleYear
Stiff person syndrome and myasthenia gravis.
    Neurology India, 2002, Volume: 50, Issue:1

    Topics: Adult; Diazepam; Electrophysiology; Female; Humans; Muscle Relaxants, Central; Myasthenia Gravis; Ne

2002